Deschloroclotizolam

Deschloroclotizolam
Legal status
Legal status
  • CA: Schedule IV
  • DE: NpSG (Industrial and scientific use only)
  • UK: Schedule 1
Identifiers
  • 2-chloro-4-phenyl-9-methyl-4H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine
CAS Number
PubChem CID
ChemSpider
UNII
Chemical and physical data
FormulaC15H11ClN4S
Molar mass314.79 g·mol−1
3D model (JSmol)
  • CC1=NN=C2N1C3=C(C=C(S3)Cl)C(=NC2)C4=CC=CC=C4
  • InChI=1S/C15H11ClN4S/c1-9-18-19-13-8-17-14(10-5-3-2-4-6-10)11-7-12(16)21-15(11)20(9)13/h2-7H,8H2,1H3
  • Key:DBAZIULAFZCKIM-UHFFFAOYSA-N

Deschloroclotizolam is a thienotriazolodiazepine derivative which has been sold as a designer drug, first being identified in Sweden in 2021.[1]

See also

References

  1. ↑ European Monitoring Centre for Drugs Drug Addiction (June 2022). New psychoactive substances: 25 years of early warning and response in Europe. An update from the EU Early Warning System (PDF). European Monitoring Centre for Drugs and Drug Addiction. doi:10.2810/882318 (inactive 11 July 2025). ISBN 978-92-9497-737-3.{{cite book}}: CS1 maint: DOI inactive as of July 2025 (link)
This page is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.